In GEPIA2, we found the higher IGF2BP2 expression was significantly associated with poor prognosis of most cancers, such as BLCA, GBM, HNSC, KIRC, LGG, LUAD, PAAD, SARC (Figure 11B). Here, IGF2BP2 is linked to bladder transitional cell carcinoma.